Trials / Completed
CompletedNCT05624788
A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives
A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives (CATORI)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study to define current care pathways for American Indian or Alaska Native patients who require specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indication requiring referral to one of the following specialists: neurologist, ophthalmologist, or oncologist. Eligible patients will have recently (≤6 months) been referred to a specialty care provider and not yet seen a specialist (in addition to meeting the other eligibility criteria). The PPD virtual site can enroll patients from anywhere across the United States. The study will collect data to determine whether a patient was seen by a specialist, diagnosed with a specialized disease, patient characteristics potentially associated with being seen or not seen by a specialist, and the reasons/barriers why a patient was not seen by a specialist through a number of patient surveys.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | Participants who self-identify as American Indian or Alaska Native with any indication requiring referral to a specialist after a primary care provider standard of care visit will be observed to collect data, using several surveys at 6 and 12 months. No additional specialty care visits will be added for the purpose of this study given the intent to observe medical care received following primary care provider referral. Referral to a specialist will be based on local clinical practice. |
Timeline
- Start date
- 2022-12-02
- Primary completion
- 2025-04-01
- Completion
- 2025-04-15
- First posted
- 2022-11-22
- Last updated
- 2025-04-25
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05624788. Inclusion in this directory is not an endorsement.